PRF Technologies Ltd. SEC filings PRFX
PRF Technologies Ltd. has 263 filings in SEC EDGAR's recent list, going back to Feb 3, 2020. Its latest annual report, Form 20-F, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Sep 3, 2026 | — |
| 424B3 | Prospectus | Jun 29, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Jun 22, 2026 | — |
| 424B3 | Prospectus | May 19, 2026 | — |
| F-1 | Registration statement (foreign issuer) | May 13, 2026 | — |
| 424B3 | Prospectus | May 9, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | May 2, 2025 | — |
| 424B5 | Prospectus supplement | Jan 2, 2025 | — |
| 424B3 | Prospectus | Dec 12, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 6, 2024 | — |
| 424B5 | Prospectus supplement | Oct 16, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 20, 2024 | — |
| POS AM | Filing | Aug 27, 2024 | — |
| 424B3 | Prospectus | Apr 17, 2024 | — |
| 424B4 | Prospectus | Apr 17, 2024 | — |
| F-1/A | Filing | Apr 15, 2024 | — |
| POS AM | Filing | Mar 13, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Mar 1, 2024 | — |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 12, 2024 | — |
| 424B3 | Prospectus | Dec 27, 2023 | — |
| 424B3 | Prospectus | Sep 5, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Aug 25, 2023 | — |
| 424B5 | Prospectus supplement | Jul 18, 2023 | — |
| 424B5 | Prospectus supplement | Jul 14, 2023 | — |
| S-8 | Employee stock plan registration | Jun 29, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Sep 3, 2021 | — |
| POS AM | Filing | Sep 3, 2021 | — |
| S-8 | Employee stock plan registration | Jul 16, 2021 | — |
| 424B3 | Prospectus | Apr 9, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Apr 1, 2021 | — |
| POS AM | Filing | Mar 22, 2021 | — |
| 424B3 | Prospectus | Nov 25, 2020 | — |
| 424B3 | Prospectus | Sep 30, 2020 | — |
| 424B4 | Prospectus | Sep 2, 2020 | — |
| F-1/A | Amendment no. 4 to form f-1 | Aug 31, 2020 | — |
| F-1/A | Amendment no. 3 to form f-1 | Aug 24, 2020 | — |
| F-1/A | Amendment no. 2 to form f-1 | Aug 10, 2020 | — |
| F-1/A | Amendment no. 1 to form f-1 | Aug 5, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jun 30, 2020 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRFX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1801834
- Former names
- PAINREFORM LTD. (until Jan 20, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.